Anzeige
Mehr »
Samstag, 25.10.2025 - Börsentäglich über 12.000 News
Das nächste Lila Sciences? Telescope Innovations ist das 30-Millionen-Dollar-Tor zu KI-gesteuerter Chemie
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A403UF | ISIN: SE0022049920 | Ticker-Symbol: LS60
Frankfurt
24.10.25 | 08:01
0,619 Euro
+2,15 % +0,013
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
CLINICAL LASERTHERMIA SYSTEMS AB Chart 1 Jahr
5-Tage-Chart
CLINICAL LASERTHERMIA SYSTEMS AB 5-Tage-Chart

Aktuelle News zur CLINICAL LASERTHERMIA SYSTEMS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
07.10.Clinical Laserthermia Systems AB: CLS-sponsored neuro LITT study in patients with malignant brain tumor shows positive results57 Lund, Sweden, October 7th, 2025 - Clinical Laserthermia Systems AB (publ) ("CLS") today announces positive results from a clinical safety study on laser ablation, performed using CLS proprietary LITT...
► Artikel lesen
30.09.Clinical Laserthermia Systems AB Raises SEK 20.9 Million Through Full Subscription of Warrants of Series TO 8 B1
CLINICAL LASERTHERMIA SYSTEMS Aktie jetzt für 0€ handeln
04.09.Clinical Laserthermia Systems Receives FDA Clearance for Expanded Labeling of the ClearPoint Prism Neuro Laser Therapy System, doubling the addressable U.S market for Neuro LITT1
04.09.Clinical Laserthermia Systems AB: Clinical Laserthermia Systems Receives FDA Clearance for Expanded Labeling of the ClearPoint Prism[] Neuro Laser Therapy System, doubling the addressable U.S market for Neuro LITT147Lund, Sweden - September 4th, 2025 - Clinical Laserthermia Systems AB (publ) ("CLS" or "the Company") today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for expansion...
► Artikel lesen
22.08.Clinical Laserthermia Systems AB: CLS publishes half-year report January - June 2025179Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today publishes its half year report January - June 2025. Second Quarter Highlights Record sales revenue of SEK 9,4M...
► Artikel lesen
27.06.Clinical Laserthermia Systems AB: Communique from the Annual General Meeting on Friday June 27th in Clinical Laserthermia Systems A3
06.06.Clinical Laserthermia Systems publishes annual report for 20242
27.05.Clinical Laserthermia Systems AB: Notice of Annual General Meeting of Clinical Laserthermia Systems AB June 27, 20251
16.05.Clinical Laserthermia Systems AB: Clinical Laserthermia Systems AB publishes Interim report for January - March 2025186Summary of the interim report (relates to the Group)Three months (01/01/2025-03/31/2025) Net sales totaled SEK 4,496,000 (SEK 3,140,000). Operating profit totaled SEK -7,868,000 (SEK -16,992,000). Profit/loss...
► Artikel lesen
28.04.ClearPoint Neuro, Inc.: ClearPoint Neuro, Together with its Partner Clinical Laserthermia Systems, Announces FDA Submission to Expand the Labeling of ClearPoint Prism to Include 1.5 T MRI181SOLANA BEACH, CA / ACCESS Newswire / April 28, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the...
► Artikel lesen
28.04.Clinical Laserthermia Systems, together with its partner ClearPoint Neuro, announces FDA submission to expand the labeling of ClearPoint Prism® to include 1.5 T MRI guidance4
15.04.Clinical Laserthermia Systems AB: Updated clinical guidelines provide clear recommendations on the use of Laser Interstitial Thermal Therapy (LITT) in patients with metastatic brain tumors and radiation necrosis178Clinical Laserthermia Systems AB (publ) ("CLS or the "Company") today announces that updated clinical guidelines with recommendations supporting the use of Laser Interstitial Thermal Therapy (LITT)...
► Artikel lesen
08.04.Clinical Laserthermia Systems AB: Proposed U.S. tariffs expected to have minimal impact on CLS business160Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or "the Company") clarifies that the proposed U.S. tariffs are expected to have minimal impact on its total business, including operations...
► Artikel lesen
21.02.Clinical Laserthermia Systems AB: Clinical Laserthermia Systems AB publishes Year-end report January - December 2024266Summary of the year-end report (relates to the Group)Full year (01/01/2024-12/31/2024) Net sales totaled SEK 18,783,000 (SEK 8,273,000). Operating profit/loss totaled SEK -54,254,000 (SEK -65,933...
► Artikel lesen
07.02.Clinical Laserthermia Systems AB: CLS co-founder and former CEO Lars-Erik Eriksson leaves the board of directors at his own request1.216Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today announces that Lars-Erik Eriksson, co-founder, long-time board member and former CEO, is leaving the board of directors...
► Artikel lesen
14.01.Clinical Laserthermia Systems AB: CLS Recaps 2024 and Provides Outlook for 2025-26559Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today announces that, in its recap of 2024, in the first nine months of 2024 compared to the same period 2023, CLS saw...
► Artikel lesen
16 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1